AstraZeneca to Pay $425 Million to End US Lawsuits Over Heartburn Drugs

Share!

Insurance Journal - Oct 03, 2023

Britain’s AstraZeneca has agreed to pay $425 million to settle about 11,000 lawsuits in the United States that claimed its heartburn drugs Nexium and Prilosec caused chronic kidney disease. AstraZeneca did not admit wrongdoing under the settlement, part of broader …...

Read Full Article

Recommended Articles

Texas Summer Camp Faces Scrutiny Over Failure to Report Deaths

Posted: Apr 16, 2026

The medical officer for the Texas summer camp where 27 girls were killed in a flood last year testif...

Trucordia Buys Connecticut’s Paradiso Insurance Services

Posted: Apr 16, 2026

Utah-based insurance broker Trucordia reports it has acquired the Paradiso Financial and Insurance S...

Inszone Acquires Kansas’ Insurance Resources Group

Posted: Apr 16, 2026

Inszone Insurance Services announced the acquisition of Insurance Resources Group, Inc. Located in O...